Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis

2018 ◽  
Vol 32 (2) ◽  
pp. 307-314 ◽  
Author(s):  
Li Xu ◽  
Xiaosong Hu ◽  
Wenli Chen
Sign in / Sign up

Export Citation Format

Share Document